GlaxoSmith to cut number of brands to 20 in India, says report
Updated : August 20, 2018 11:15 AM IST
The UK-based drugmaker which has patented brands such as Calpol, Augmentin, Zinetac among others said it is planning on bringing more intellectual property products to India, especially in the respiratory and anti-infective space.
The top 10 brands of the company contributes almost 52.1 percent of GSK India’s sale.
In the past one year, the company has reduced the number of brands from 130 to 70, the report said.